Oppenheimer’s revised price target implies that shares of Amazon could surge another 29% from here.
Morgan Stanley upgrades Johnson & Johnson, sees upside on robust drug pipeline
Morgan Stanley’s price target implies that shares of Johnson & Johnson could rise another 17%.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
The S&P 500 jumped to a fresh all-time high and closed at a record on Tuesday.
This energy ETF is set to break through a key level, charts show. Two ways to play the trend
The State Street Energy Select Sector SPDR ETF (XLE) is poised to break through a resistance level of $50, the charts suggest.
Your income-generating investments could create a tax bill. How to prepare for the season
The tax-filing season officially kicked off on Monday. Investors should watch their mailboxes for key documents they’ll need to complete their returns.
What investors piling into gold and silver can learn from King Henry VIII
A Deutsche Bank analyst argues those betting on the “debasement trade” may be operating from a faulty premise.
Forget the 60/40 portfolio. This investor is 70/30 stocks and cash
Ken Mahoney, CEO of Mahoney Asset Management, said investors should hold onto a “meaningful amount” of cash this year.
RBC sees a bunch of red flags on Palantir ahead of earnings, sees stock eventually falling 70%
RBC said that shares of Palantir are still trading at an “unfavorable” risk-reward ratio, despite shedding 9% over the past three months.
Apple shares may be rangebound post earnings. How to use options to wring out profits anyway
Options are pricing in a move of a little more than $10 in either direction post-earnings, giving a clear sense of the size, even if the direction is unknown.
Big Tech stocks have been stuck for months. One top tech analyst says it’s time to buy
Melius Research’s Ben Reitzes sees upside ahead for Nvidia, Broadcom and Microsoft as enthusiasm for makers of components that are in short supply winds down.